Medical and Science
What powers GenesisCare’s bold path in cancer research: Clinical Trials Day

What does it take to deliver research that truly changes lives? For Sonya McColl, National Research Manager of Oncology at GenesisCare, the Clinical Trials Day (20 May) theme of Powered by Purpose is more than a timely message, it’s a daily reality.
In this Health Industry Hub podcast, McColl explores how GenesisCare approaches clinical trials through a purpose-led lens, from the way research areas are selected to how funding is sourced from industry partnerships, academic collaborations, and other channels.
But McColl is also frank about the challenges. Diversity in trial participation and incorporating the patient voice more meaningfully into trial design is another critical frontier.
She reflects on recent prostate and breast cancer research milestones at GenesisCare and highlights their significant potential to improve patient outcomes, while also unpacking the economic and operational tensions of running local trials versus serving as a site within global studies. Despite Australia’s strong clinical trials reputation, several barriers continue to hold the sector back.
Looking ahead, McColl spotlights the emerging trends set to reshape oncology research that could dramatically shift the pace and precision of future clinical trials.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News - Pharmaceuticals

Minister Butler rewrites the playbook with unconventional Chief of Staff appointment
In a move that has taken many by surprise, Federal Minister for Health, Aged Care and Disability, Mark Butler, has […]
MoreNews - MedTech & Diagnostics

What Philips’ new report adds to the ‘AI in healthcare’ debate
Ten years in, the Future Health Index (FHI) lands with sharp relevance – less a forecast, more a mirror. In […]
MoreNews - Pharmaceuticals

Merck backs landmark move to standardise paediatric hormone testing across Australasia
A new set of expert-backed protocols is set to reshape how endocrine disorders are diagnosed and managed in children across […]
More